Sign in

You're signed outSign in or to get full access.

Omega Fund Management, LLC

CIK:0001637359
Venture Capital
$2B AUM
13 holdings
Boston, MA, United States
Founded:2004
23 employees
Latest filing:Jun 30, 2025

Omega Fund Management, LLC is a Boston-based venture capital firm founded in 2004 focused on supporting exceptional founders and entrepreneurs developing impactful products and platforms across multiple therapeutic areas. The firm specializes in life sciences and biotechnology investments, operates internationally, and employs approximately 23 professionals, serving institutional investors and emerging companies in the healthcare and biopharmaceutical sectors.

Investment Strategy

Omega Fund Management specializes in providing venture capital to companies in the life sciences and healthcare sectors, targeting opportunities with transformative potential in biotechnology and therapeutics. The firm partners with exceptional scientific founders and entrepreneurs, leveraging its deep industry experience, operational expertise, and global network to accelerate portfolio company growth. Omega emphasizes impactful innovation, cross-stage investments, and long-term partnerships to maximize value creation.

Latest 13F Filing Activity

Omega Fund Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 12 equity positions with a total 13F market value of $154M. The fund increased holdings in Upstream Bio Inc., Beta Bionics Inc., Sana Biotechnology, Inc. among other positions. Omega Fund Management, LLC reduced exposure to Kestra Med Technologies LTD., Bicara Therapeutics Inc., Alumis Inc. among others.

Top Buys
U
UPBUpstream Bio Inc.
+$9.9M
B
BBNXBeta Bionics Inc.
+$4.6M
A
ALMSAlumis Inc.
-$2.1M
N
NUVBNuvation Bio
-$1.5M
R
REPLReplimune Group
-$908.6K
Top Sells
K
KMTSKestra Med Technologies Ltd.
-$17.5M
B
BCAXBicara Therapeutics Inc.
-$8.2M
A
ALMSAlumis Inc.
-$2.1M
N
NUVBNuvation Bio
-$1.5M
R
REPLReplimune Group
-$908.6K

Top Holdings

B
BBNXBeta Bionics Inc.
+18.7%$28.9M
K
KMTSKestra Med Technologies Ltd.
+17.7%$27.3M
U
UPBUpstream Bio Inc.
+14.5%$22.4M
N
NUVBNuvation Bio
+13.9%$21.5M
B
BCAXBicara Therapeutics Inc.
+13.3%$20.5M

Equity Positions (12)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
Beta Bionics Inc.18.75%$28.9M1,988,287$12.24$14.56+$4.6M
Kestra Med Technologies Ltd.17.67%$27.3M1,645,893$24.92$16.58-$17.5M
Upstream Bio Inc.14.48%$22.4M2,036,293$16.44$10.98+$9.9M
Nuvation Bio13.94%$21.5M11,042,728$10.45$1.95-$1.5M
Bicara Therapeutics Inc.13.26%$20.5M2,204,650$25.47$9.29-$8.2M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+43.0%
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
+34.7%
BLANK CHECKS
+17.1%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+5.1%

Investment Team (2)

NameRoleLocationLinkedIn
N
Noelle Hutchins
Senior AssociateBoston, MA , United States
Bernard DAVITIAN
Bernard DAVITIAN
PartnerUnited States